Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir.

Antiviral therapy - 1 Apr 2004

Lastere Stephane, Dalban Cecile, Collin Gilles, Descamps Diane, Girard Pierre-Marie, Clavel Francois, Costagliola Dominique, Brun-Vezinet Francoise

Abstract excerpt

We evaluated the impact of genetic changes within p6Gag gene on the virological response (VR, mean decrease in plasma viral load at week 12) to unboosted amprenavir (APV). Gag-protease fragments, including gag p2, p7, p1, p6 regions and whole protease (PR) were sequenced from baseline plasma spec...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Motifs
Share to Carbamates
Share to Furans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to gag Gene Products, Human Immunodeficiency Virus

Share to Gene Products, gag

Share to HIV Protease Inhibitors

Share to Sulfonamides

Share to Viral Load

Source

Identifiers

PMID: 15134184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15134184-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir.PMID 15134184Read ↗

Resistance to Nucleoside Analog Reverse Transcriptase Inhibitors Mediated by Human Immunodeficiency Virus Type 1 p6 ProteinSemantic proximity Read ↗

Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy.Semantic proximity Read ↗

Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients.Semantic proximity Read ↗

Accumulation of P(T/S)AP late domain duplications in HIV type 1 subtypes B, C, and F derived from individuals failing ARV therapy and ARV drug-naive patients.Semantic proximity Read ↗

Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients.Semantic proximity Read ↗

Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late DomainSemantic proximity Read ↗

Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.Semantic proximity Read ↗

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.Semantic proximity Read ↗

Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.Semantic proximity Read ↗

Amino acid substitutions at the HIV-1 transframe region significantly impair virus infectivity.Semantic proximity Read ↗

A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure.Semantic proximity Read ↗

Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.